OncoMatch/Clinical Trials/NCT06905132
Preoperative 5-Day Radiotherapy for Soft Tissue Sarcoma
Is NCT06905132 recruiting? Yes, currently enrolling (Jun 2026). This Phase 2 trial studies non-drug interventions for soft tissue sarcoma.
The purpose of this research study is to preserve healthy tissue around the cancer on the arm(s) and/or leg(s) using Hypofractionated radiotherapy, while treating the cancer and preventing it from spreading to other areas of the body.
Check if I qualifyExtracted eligibility criteria
Cancer type
Sarcoma
Disease stage
Excluded: Stage DISTANT METASTATIC DISEASE
Distant metastatic disease [excluded]
Performance status
ECOG 0–3(Limited self-care)
Prior therapy
Cannot have received: radiation therapy
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- Medical University of South Carolina · Charleston, South Carolina
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT06905132 currently recruiting?
Yes, this trial is currently recruiting patients.
Are there prior therapy exclusions?
Yes. Prior radiation therapy disqualifies patients from enrollment.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages